Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Peter Thiel
MedTech
Neuralink nabs $280M after scoring FDA trial nod
Elon Musk's Neuralink has the go-ahead from the FDA to begin clinical trials—and now, it has secured funding to see the studies through.
Andrea Park
Aug 8, 2023 12:32pm
John Mascola moves on from NIAID's R&D hub—Chutes and Ladders
Apr 1, 2022 9:30am
Palantir snags IBM Watson Health vet to be first CMO
May 3, 2021 7:00am
Alloy Therapeutics nabs a $75M series C
Apr 2, 2021 8:55am
The money keeps coming for Eli Lilly COVID-19 partner AbCellera
May 27, 2020 7:45am
Merck KGaA, Palantir form new JV aimed at sharing cancer data
Nov 19, 2018 11:35am
